Shenzhen University | China
Dr. Yanpeng Li is a pharmacology researcher at Shenzhen University with interdisciplinary expertise spanning pharmaceutical chemistry, immunology, and targeted drug discovery. He earned his PhD in Pharmacology from Southern Medical University and completed joint doctoral training at the Karolinska Institutet under Nobel Committee member Prof. Rikard Holmdahl, where his research centered on natural medicinal flavonoids, particularly kaempferol, in autoimmune diseases and virus immunology. Dr. Li further strengthened his international research profile through postdoctoral training in viral immunology at the Karolinska Institutet and is currently pursuing postdoctoral research at Shenzhen University, focusing on targeted therapeutic strategies for acute myeloid leukemia. His academic and professional journey reflects a strong integration of basic pharmacological mechanisms with translational drug development. Dr. Li is an active member of several professional bodies, including the Editorial Board of the International Conference on Disease Genetics and Genomics, the Clinical Rational Drug Use Committee of the Shenzhen Medical Doctor Association, and the Swedish Pharmacists’ Association. His research interests encompass natural compounds, autoimmune disorders such as rheumatoid arthritis, psoriasis, and systemic lupus erythematosus, viral immunology, acute myeloid leukemia, and precision-targeted therapies. In recognition of his academic excellence, he has received multiple scholarships and awards from institutions in China and Sweden. Overall, Dr. Li’s work contributes significantly to advancing targeted therapeutics and evidence-based pharmacological innovation.
View ORCID Profile
Featured Publications